Abbott’s Stent To Treat Patients At Risk Of Stroke

Abbott received FDA approval for the Xact® Carotid Stent and 510(k) clearance for the Emboshield® Embolic Protection System to treat patients at risk of stroke who are not favorable candidates for surgery.
The new system features a stent specifically designed to treat diseased carotid arteries – arteries in the neck that have become clogged or partially blocked due to the build-up of fatty plaque and debris (atherosclerosis). The Xact stent is self-expanding and has a closed-cell design that creates a tightly knit yet highly flexible mesh intended to help restore the inner diameter of a carotid artery, promote a smooth inner vessel surface, and potentially reduce the release of fatty debris (emboli) from a diseased vessel when it is treated, which can lead to stroke.
The Xact stent is designed for use in combination with the fully retractable Emboshield filter. Emboshield is designed to capture emboli that can break off during a carotid stenting procedure, and it is the only filter to feature Barewire™, a proprietary technology developed to allow for better control of stent placement once the filter is in place and fully apposed against the vessel wall.
Find out more at Abbott Vascular Devices…